Unione Europea - italiano - EMA (European Medicines Agency)

gilead sciences ireland uc - cobicistat - infezioni da hiv - antivirali per uso sistemico - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - cobicistatum - compresse rivestite con film - cobicistatum 150 mg, silice colloidalis anhydrica, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme, magnesio stearas, Überzug: poli(alcole vinylicus), macrogolum 3350, talco, e 110 0,32 mg, e 171, e 172 (giallo), per compresso haze corrisp. sodio 2.1 mg. - le infezioni da hiv - synthetika